|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/79 | |
| C12N 9/90 | |||
| C12N 15/81 | |||
| C07K 14/395 |
| (11) | Patento numeris | 1831375 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05823505.2 |
| Europos patento paraiškos padavimo data | 2005-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-09-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2005/005085 |
| Data | 2005-12-23 |
| (87) | Numeris | WO 2006/067511 |
| Data | 2006-06-29 |
| (30) | Numeris | Data | Šalis |
| PCT/GB2004/0054 | 2004-12-23 | WO | |
| PCT/GB2004/0054 | 2004-12-23 | WO |
| (72) |
Finnis, Christopher John Arthur, GB
Sleep, Darrell, GB
Shuttleworth, Gillian, GB
|
| (73) |
Novozymes Biopharma DK A/S,
Krogshoejvej 36, 2880 Bagsvaerd,
DK
|
| (54) | GENE EXPRESSION TECHNIQUE |
| GENE EXPRESSION TECHNIQUE |